0000920465-15-000082.txt : 20151223
0000920465-15-000082.hdr.sgml : 20151223
20151223164118
ACCESSION NUMBER: 0000920465-15-000082
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20151221
FILED AS OF DATE: 20151223
DATE AS OF CHANGE: 20151223
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: LA JOLLA PHARMACEUTICAL CO
CENTRAL INDEX KEY: 0000920465
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 330361285
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10182 TELESIS COURT, 6TH FLOOR
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-207-4264
MAIL ADDRESS:
STREET 1: 10182 TELESIS COURT, 6TH FLOOR
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: TIDMARSH GEORGE F
CENTRAL INDEX KEY: 0001287235
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36282
FILM NUMBER: 151306231
4
1
wf-form4_145090686812879.xml
FORM 4
X0306
4
2015-12-21
0
0000920465
LA JOLLA PHARMACEUTICAL CO
LJPC
0001287235
TIDMARSH GEORGE F
C/O LA JOLLA PHARMACEUTICAL COMPANY,
10182 TELESIS COURT, 6TH FLOOR
SAN DIEGO
CA
92121
1
1
0
0
President, CEO & Secretary
Stock Option (Right to Buy)
28.24
2015-12-21
4
A
0
289000
0
A
2025-12-21
Common Stock
289000.0
289000
D
This option represents a right to purchase a total of 289,000 shares of the Issuer's Common Stock one quarter of which shall be fully vested and exercisable on December 21, 2016, with the remaining 216,750 shares vesting monthly thereafter over the next three years.
/s/ Ryan Murr, as attorney-in-fact for George F. Tidmarsh
2015-12-23